Parameter | Unvariate | Multivariatea | ||||||
---|---|---|---|---|---|---|---|---|
P value | Hazard ratio | 95 % hazard ratio confidence limits | P value | Hazard ratio | 95 % hazard ratio confidence limits | |||
Gender | ||||||||
Male | <0.001 | 0.71 | 0.58 | 0.86 | 0.33 | 0.88 | 0.69 | 1.13 |
Female | – | 1.00 | – | – | – | 1.00 | – | – |
HIV risk group | ||||||||
MSM | 0.01 | 0.68 | 0.51 | 0.92 | 0.17 | 0.77 | 0.55 | 1.11 |
Heterosexual | – | 1.00 | – | – | – | 1.00 | – | – |
IDU | 0.01 | 1.41 | 1.08 | 1.84 | 0.09 | 1.31 | 0.96 | 1.81 |
Other | 0.50 | 1.24 | 0.66 | 2.34 | 0.59 | 1.19 | 0.62 | 2.29 |
Unknown | 0.70 | 1.08 | 0.72 | 1.62 | 0.82 | 1.05 | 0.69 | 1.61 |
Nadir CD4 value | ||||||||
Per 100 increase | 0.002 | 0.88 | 0.81 | 0.96 | 0.017 | 0.89 | 0.81 | 0.98 |
Age in years | ||||||||
Per 1 year increase | 0.07 | 0.97 | 0.94 | 1.0 | 0.07 | 0.97 | 0.93 | 1.00 |
Anti-HCV Ab | ||||||||
Positive | <0.001 | 1.62 | 1.32 | 1.98 | 0.58 | 1.08 | 0.81 | 1.44 |
Negative | – | 1.00 | – | – | – | 1.00 | – | – |
Unknown | 0.13 | 1.3 | 0.93 | 1.82 | 0.37 | 1.20 | 0.81 | 1.77 |
Anti-HBc Ab | ||||||||
Positive | 0.01 | 1.37 | 1.07 | 1.75 | 0.36 | 1.14 | 0.87 | 1.49 |
Negative | – | 1.00 | – | – | – | 1.00 | – | – |
Unknown | 0.34 | 1.11 | 0.89 | 1.39 | 0.86 | 1.02 | 0.80 | 1.31 |
Baseline hemoglobin | ||||||||
Per 1 g/dL increase | 0.01 | 0.93 | 0.88 | 0.98 | 0.71 | 0.99 | 0.92 | 1.06 |
ARV group | ||||||||
PI | 0.87 | 1.02 | 0.82 | 1.27 | 0.49 | 0.92 | 0.74 | 1.16 |
NNRTI | – | 1.00 | – | – | – | 1.00 | – | – |
ITI | 0.97 | 0 | 0 | 0.96 | 0 | 0 | – | |
FI | 0.56 | 0.71 | 0.23 | 2.25 | 0.68 | 0.78 | 0.25 | 2.48 |
Late presenter | ||||||||
Yes | 0.87 | 0.98 | 0.81 | 1.19 | 0.20 | 0.86 | 0.69 | 1.08 |